AZNAstraZeneca PLC
1577.50SEK+1.09%Mkt Cap: 231.49B $P/E: 24.51

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…

Key Statistics

Company
Market Cap231.49B $
Enterprise Value234.14B $
Revenue (TTM)5.87B $
Gross Profit4.60B $
Net Income (TTM)978.04M $
Revenue/Share3.787 USD
Last Price1577.50 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees96.1K
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)24.51
P/E (Forward)15.34
PEG1.41
EV/EBITDA122.98
EV/Revenue39.89
P/S39.16
P/B47.78
EPS (TTM)63.67
EPS (Forward)
52W Range
1365.0038% of range1925.50
52W High1925.50 SEK
52W Low1365.00 SEK
Profitability
Gross Margin81.90%
Oper. Margin23.46%
EBITDA Margin32.44%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth6.40%
Earnings Growth2.50%
Cash Flow & Leverage
Operating CF1.39B $
CapEx (TTM)564.83M $
FCF Margin7.99%
FCF Yield0.20%
Net Debt2.62B $
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.60
Current Ratio0.89
Quick Ratio0.66
Book Value/Sh32.43 SEK
Cash/Share3.203 SEK
Dividends
Fwd Div Rate30.08 SEK
Trail. Div Rate3.230 SEK
Div. Yield1.93%
5Y Avg Yield2.05%
Payout Ratio47.41%
Ex-Div DateAug 6, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)1890.68 SEK
Upside (mean)+19.9%
Target Range1685.62 SEK2041.83 SEK
SEK1685.62+19.9% to meanSEK2041.83
# Analysts3
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions65.09%
Technical
SMA 501661.94 (-5.1%)
SMA 2001728.60 (-8.7%)
Beta0.21
S&P 52W Chg18.16%
Avg Vol (30d)681.05K
Avg Vol (10d)611.64K
Technical Indicators
RSI (14)46.5
MACD-40.3382
MACD Signal-46.4403
MACD Hist.+6.1021
BB Upper1711.65 SEK
BB Middle1568.08 SEK
BB Lower1424.50 SEK
BB Width18.31%
ATR (14)44.54 SEK
Vol Ratio (20d)0.83x